Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer
A phase 2 trial of RBS2418 in colorectal cancer, run by Riboscience, LLC., now recruiting.
Overview
Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer is a phase 2 interventional study registered as NCT06824064 by Riboscience, LLC., with 150 participants planned, started 2025-01-17 and due to reach its primary completion in 2027-12. Interventions recorded: RBS2418 and Placebo.
Similar pages
not linked directly; found by shared links- TrialXian-Lian-Jie-Du Optimization Decoction As an Adjuvant Treatment for Prevention of Recurrence of Colon Cancer
Shares Colorectal cancer and the tag pipeline.
- TrialA Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer
Shares Colorectal cancer and the tag pipeline.
- TrialA First-In-Human Trial of pTTL in Advanced Colorectal Cancer
Shares Colorectal cancer and the tag pipeline.
- TrialEvaluation of Gixam's Performance in a FIT Negative Population
Shares Colorectal cancer and the tag pipeline.
- TrialIsunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
Shares Colorectal cancer and the tag pipeline.
- TrialTo Evaluate Dose and Safety of NanoEcho Particle-1 Using NanoEcho Imaging Device Examinations of Rectal Lymph Nodes in Healthy Volunteers and Rectal Cancer Patients.
Shares Colorectal cancer and the tag pipeline.
- TrialA Clinical Study of Arfolitixorin in Patients With mCRC
Shares Colorectal cancer and the tag pipeline.
- TrialFirst-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer
Shares Colorectal cancer and the tag pipeline.